Patent · US Active

Coumarin derivatives useful as TNFα inhibitors

US7872142B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignee

CHUGAI SEIYAKU KABUSHIKI KAISHA · JP

Inventors

Jie Fei Cheng · Carlsbad, US
Thomas Arrhenius · Del Mar, US
David Mark Wallace · San Diego, US
Mi Chen · San Diego, US
Sovouthy Tith · San Diego, US
Hirotaka Kashiwagi · Shizuoka, JP
Yoshiyuki Ono · Shizuoka, JP
Yoshiaki Watanabe · Tokyo, JP

Key dates

Filing date	Mar 18, 2010
Grant date	Jan 18, 2011
Priority date	—
Expiry date	Mar 18, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel compounds composition capable of inhibiting TNFα and having antiimmunoinflammatory and autoimmune properties useful in a pharmaceutical composition, such as for a drug containing this as an active ingredient; and a therapeutic method with the use of these novel compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.